Pages that link to "Q38012254"
Jump to navigation
Jump to search
The following pages link to Drugging Wnt signalling in cancer (Q38012254):
Displaying 50 items.
- Pediatric medulloblastoma - update on molecular classification driving targeted therapies (Q21129295) (← links)
- Wnt/beta-catenin signaling and small molecule inhibitors (Q24597197) (← links)
- Targeted disruption of the BCL9/β-catenin complex inhibits oncogenic Wnt signaling (Q24632740) (← links)
- A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers (Q26739665) (← links)
- Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma (Q26827487) (← links)
- Current Understanding on EGFR and Wnt/β-Catenin Signaling in Glioma and Their Possible Crosstalk (Q26865911) (← links)
- Structural Insights into the Inhibition of Wnt Signaling by Cancer Antigen 5T4/Wnt-Activated Inhibitory Factor 1 (Q27681929) (← links)
- Wnt Drug Discovery: Weaving Through the Screens, Patents and Clinical Trials (Q28078703) (← links)
- Histone methylation modifiers in cellular signaling pathways (Q28082123) (← links)
- A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling. (Q30370900) (← links)
- Targeting Colorectal Cancer Proliferation, Stemness and Metastatic Potential Using Brassicaceae Extracts Enriched in Isothiocyanates: A 3D Cell Model-Based Study. (Q33616786) (← links)
- Inhibition of cancer cell migration and invasion through suppressing the Wnt1-mediating signal pathway by G-quadruplex structure stabilizers (Q33652068) (← links)
- Epigenetics: an emerging player in gastric cancer (Q33718259) (← links)
- Thermodynamics in Gliomas: Interactions between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma (Q33748280) (← links)
- Salinomycin suppresses LRP6 expression and inhibits both Wnt/β-catenin and mTORC1 signaling in breast and prostate cancer cells (Q34052780) (← links)
- Multi-targeted therapy of cancer by niclosamide: A new application for an old drug. (Q34199032) (← links)
- Crosstalk between microRNA30a/b/c/d/e-5p and the canonical Wnt pathway: implications for multiple myeloma therapy (Q34287900) (← links)
- Morphogen pathways as molecular targets for the treatment of fibrosis in systemic sclerosis (Q34315290) (← links)
- β-Catenin-independent activation of TCF1/LEF1 in human hematopoietic tumor cells through interaction with ATF2 transcription factors (Q34961818) (← links)
- Clinical significance of frizzled homolog 3 protein in colorectal cancer patients (Q35047404) (← links)
- Ligand-independent canonical Wnt activity in canine mammary tumor cell lines associated with aberrant LEF1 expression (Q35179788) (← links)
- Denervation suppresses gastric tumorigenesis (Q35219277) (← links)
- Expression of Glypican 3 in low and high grade urothelial carcinomas. (Q35552355) (← links)
- Can we safely target the WNT pathway? (Q35591995) (← links)
- Targets of Wnt/ß-catenin transcription in penile carcinoma (Q35611249) (← links)
- Zinc Protoporphyrin Suppresses β-Catenin Protein Expression in Human Cancer Cells: The Potential Involvement of Lysosome-Mediated Degradation (Q35639288) (← links)
- Network-Based Analysis of Nutraceuticals in Human Hepatocellular Carcinomas Reveals Mechanisms of Chemopreventive Action (Q35861710) (← links)
- Identification of Wnt Pathway Target Genes Regulating the Division and Differentiation of Larval Seam Cells and Vulval Precursor Cells in Caenorhabditis elegans (Q35926368) (← links)
- Diverse Basis of β-Catenin Activation in Human Hepatocellular Carcinoma: Implications in Biology and Prognosis (Q35995682) (← links)
- WNT7A Regulation by miR-15b in Ovarian Cancer (Q36022349) (← links)
- The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cells. (Q36051868) (← links)
- The evolving roles of canonical WNT signaling in stem cells and tumorigenesis: implications in targeted cancer therapies (Q36515479) (← links)
- SRSF1 and SRSF9 RNA binding proteins promote Wnt signalling-mediated tumorigenesis by enhancing β-catenin biosynthesis (Q36870110) (← links)
- Identification of quinazoline compounds as novel potent inhibitors of Wnt/β-catenin signaling in colorectal cancer cells (Q36998222) (← links)
- Direct Targeting of β-Catenin by a Small Molecule Stimulates Proteasomal Degradation and Suppresses Oncogenic Wnt/β-Catenin Signaling (Q37119601) (← links)
- Direct Pharmacological Inhibition of β-Catenin by RNA Interference in Tumors of Diverse Origin (Q37231321) (← links)
- Logical design of an anti-cancer agent targeting the plant homeodomain in Pygopus2 (Q37252279) (← links)
- Topoisomerase IIα mediates TCF-dependent epithelial-mesenchymal transition in colon cancer (Q37282291) (← links)
- Skeletal metastasis: treatments, mouse models, and the Wnt signaling (Q37354085) (← links)
- Identification of a new class of WNT1 inhibitor: Cancer cells migration, G-quadruplex stabilization and target validation (Q37708736) (← links)
- Rottlerin induces Wnt co-receptor LRP6 degradation and suppresses both Wnt/β-catenin and mTORC1 signaling in prostate and breast cancer cells (Q37735226) (← links)
- Intersection of Hippo/YAP and Wnt/β-catenin signaling pathways (Q38048637) (← links)
- Protein arginine methyltransferases and cancer (Q38067063) (← links)
- Morphogen pathways in systemic sclerosis (Q38071976) (← links)
- Canonical Wnt signalling as a key regulator of fibrogenesis - implications for targeted therapies? (Q38151902) (← links)
- Regulation of Wnt/β-catenin signaling by posttranslational modifications (Q38193259) (← links)
- Cancer-associated fibroblasts as another polarized cell type of the tumor microenvironment (Q38204745) (← links)
- Safely targeting cancer stem cells via selective catenin coactivator antagonism (Q38224211) (← links)
- A colorful history: the evolution of indigoids. (Q38258171) (← links)
- Molecular biology of pediatric brain tumors and impact on novel therapies (Q38359284) (← links)